HK1174533A1 - Method for inhibiting tumor metastasis - Google Patents

Method for inhibiting tumor metastasis

Info

Publication number
HK1174533A1
HK1174533A1 HK13101395.4A HK13101395A HK1174533A1 HK 1174533 A1 HK1174533 A1 HK 1174533A1 HK 13101395 A HK13101395 A HK 13101395A HK 1174533 A1 HK1174533 A1 HK 1174533A1
Authority
HK
Hong Kong
Prior art keywords
tumor metastasis
inhibiting tumor
tumor cell
inhibit tumor
metastasis
Prior art date
Application number
HK13101395.4A
Other languages
English (en)
Inventor
Masako Nozaki
Original Assignee
Inflammation Res Ct Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inflammation Res Ct Company Ltd filed Critical Inflammation Res Ct Company Ltd
Publication of HK1174533A1 publication Critical patent/HK1174533A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK13101395.4A 2004-07-14 2008-02-22 Method for inhibiting tumor metastasis HK1174533A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58750704P 2004-07-14 2004-07-14

Publications (1)

Publication Number Publication Date
HK1174533A1 true HK1174533A1 (en) 2013-06-14

Family

ID=35907711

Family Applications (2)

Application Number Title Priority Date Filing Date
HK13101395.4A HK1174533A1 (en) 2004-07-14 2008-02-22 Method for inhibiting tumor metastasis
HK08101954.4A HK1108118A1 (en) 2004-07-14 2008-02-22 Method for inhibiting tumor metastasis

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK08101954.4A HK1108118A1 (en) 2004-07-14 2008-02-22 Method for inhibiting tumor metastasis

Country Status (10)

Country Link
US (3) US20080206203A1 (ja)
EP (2) EP1765333A4 (ja)
JP (1) JP3983272B2 (ja)
KR (1) KR101213926B1 (ja)
CN (2) CN101022796B (ja)
AT (1) ATE481968T1 (ja)
BR (1) BRPI0513351A (ja)
DE (1) DE602005023797D1 (ja)
HK (2) HK1174533A1 (ja)
WO (1) WO2006019874A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014175253A1 (ja) * 2013-04-22 2014-10-30 株式会社栃木臨床病理研究所 抗腫瘍剤
TWI626046B (zh) * 2015-10-06 2018-06-11 高雄醫學大學 用於預防或治療肺癌的醫藥組合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528060A (en) 1982-07-08 1985-07-09 Hercules Incorporated Apparatus for winding of filamentary composites
US4720505A (en) * 1983-06-27 1988-01-19 Merck Frosst Canada, Inc. Leukotriene antagonists
CA1261835A (en) * 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
JPS63258879A (ja) 1987-04-16 1988-10-26 Mitsubishi Kasei Corp ビニルチアゾ−ル誘導体およびそれを有効成分とするロイコトリエン拮抗剤
JPS63258854A (ja) 1987-04-16 1988-10-26 Mitsubishi Kasei Corp カルボキシスチレン誘導体およびそれを有効成分とする薬剤
US4985585A (en) 1988-03-07 1991-01-15 Kyorin Pharmaceutical Co., Ltd. Phenoxyalkylcarboxylic acid derivatives and process for their preparations
JPH02169583A (ja) 1988-12-22 1990-06-29 Mitsubishi Kasei Corp ビニルチアゾール誘導体およびそれを有効成分とする薬剤
US5079261A (en) 1989-04-28 1992-01-07 Brigham And Women's Hospital Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
JP2600644B2 (ja) 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
GB9119001D0 (en) 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
US5428060A (en) * 1992-08-27 1995-06-27 Merck Frosst Canada, Inc. Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis
JPH06116163A (ja) * 1992-10-05 1994-04-26 Toagosei Chem Ind Co Ltd 腫瘍抑制剤
DE4424714A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
US5552437A (en) * 1994-10-27 1996-09-03 Merck Frosst Canada, Inc. Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
US5527827A (en) * 1994-10-27 1996-06-18 Merck Frosst Canada, Inc. Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
US5876760A (en) * 1995-06-12 1999-03-02 Ono Pharmaceutical Co., Ltd. Granules containing pranlukast, process for producing the granules, and method of improving adhesiveness of pranlukast
GB9525261D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Carbamic acid derivatives
US6207654B1 (en) * 1996-05-03 2001-03-27 Bashir Zikria Capillary membrane stabilization and reduction of inflammation during the course of chemotherapy or antiviral treatment through the use of biodegradable macromolecules and interleukin-2
US5911776A (en) 1996-12-18 1999-06-15 Unisys Corporation Automatic format conversion system and publishing methodology for multi-user network
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
EP1021716A1 (en) * 1997-02-05 2000-07-26 University of Wales College of Medicine Measurement of plasma volume
DE69805033T2 (de) 1997-09-26 2002-11-14 Kowa Co Tetrazolderivate als LTD4 und H1 Antagonisten
CA2307614A1 (en) 1997-10-23 1999-04-29 Elliot P. Friedman Pharmaceutical grade echinacea
CA2332272A1 (en) 1998-05-15 1999-11-25 University Of Vermont Novel analogs of 16-hydroxyeicosatetraenoic acid
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6221880B1 (en) 1998-10-09 2001-04-24 Schering Corporation Composition and method for treating allergic diseases
WO2000021564A1 (en) * 1998-10-09 2000-04-20 Schering Corporation Composition and method for treating allergic diseases
US6194432B1 (en) 1998-10-13 2001-02-27 Fred D. Sheftell Prevention and treatment of migraine, cluster and other recurrent headaches using leukotriene antagonist drugs
AUPP910699A0 (en) * 1999-03-10 1999-04-01 Pharmalink International Limited Inhibitor of lipoxygenase pathways
CA2378880C (en) * 1999-07-21 2010-02-23 Omeros Medical Systems, Inc. Solutions and methods for inhibition of pain, inflammation and cartilage degradation
KR100381834B1 (ko) * 2000-05-20 2003-04-26 이상득 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법
DE10052333A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Sulfooxybenzamide
DE10052658A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Pyranosidderivate
EP1424101A3 (en) * 2002-11-29 2004-08-18 NOZAKI, Masako Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis
US7148248B2 (en) * 2002-11-29 2006-12-12 Masako Nozaki Method of treating or inhibiting the development of brain inflammation and sepsis

Also Published As

Publication number Publication date
US20080206203A1 (en) 2008-08-28
CN102847155A (zh) 2013-01-02
KR20070051855A (ko) 2007-05-18
KR101213926B1 (ko) 2012-12-18
EP1997491A1 (en) 2008-12-03
ATE481968T1 (de) 2010-10-15
DE602005023797D1 (de) 2010-11-04
CN101022796B (zh) 2013-02-27
WO2006019874A1 (en) 2006-02-23
CN101022796A (zh) 2007-08-22
JP2007514002A (ja) 2007-05-31
EP1765333A1 (en) 2007-03-28
EP1997491B1 (en) 2010-09-22
CN102847155B (zh) 2014-04-16
US20170014384A1 (en) 2017-01-19
BRPI0513351A (pt) 2008-05-06
HK1108118A1 (en) 2008-05-02
EP1765333A4 (en) 2008-06-18
JP3983272B2 (ja) 2007-09-26
US20190060278A1 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
WO2009083769A3 (en) Downhole fluid analysis
NO20075379L (no) Fremgangsmate ved vedlikehold av en bronn med bronnvaeske omfattende et elastisk materiale.
WO2003039443A3 (en) Novel genetic markers for leukemias
EA201070263A1 (ru) Система и способ наклонно-направленного бурения ствола скважины роторной системой бурения
DK1769199T3 (da) Vandsumpstruktur
NO20053552D0 (no) Kontrollering av transiente trykkforhold i en bronnboring.
MX2007006993A (es) Optimizacion geometrica de trayectorias de pozos multiples.
WO2008104380A3 (en) Multiplex detection of tumour cells using a panel of agents binding to extracellular markers
BR0109998B1 (pt) mÉtodo de otimizar a taxa de broca de penetraÇço enquanto perfura.
WO2007105101A3 (en) Mobile drilling rig with dual carriers
NO20060839L (no) Stromningsstyring
CA2533008A1 (en) Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using same
DK1838874T3 (da) Fremgangsmåder til regulering af stamceller
ATE368651T1 (de) Pyridazinon-derivate als gsk-3beta-hemmer
EP1732139A4 (en) THIN FILM SOLAR CELL SUBSTRATE, PROCESS FOR PRODUCING THE SAME, AND THIN FILM SOLAR CELL EMPLOYING THE SUBSTRATE
BRPI1011256A2 (pt) "fluido de perfuração, e, método."
DE602005007633D1 (de) Wärmegeregelte, fluidische selbstmontage
EP1811023A4 (en) SPECIFICALLY EXPRESSED IN ES CELLS AND USE THEREOF
NO20024047D0 (no) Fremgangsmåte for kontroll og drift av en elektrolysecelle, samt celle for utövelse av fremgangsmåten
FI20030320A0 (fi) Järjestely kallioporauksen ohjaamiseksi
MX2013002367A (es) Deteccion y correccion de flujo de fluido no deseado entre zonas subterraneas.
NO20042756L (no) Francisturbin.
HK1115878A1 (en) (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
HK1174533A1 (en) Method for inhibiting tumor metastasis
TW200621756A (en) Method for manufacturing enantiomeric imidazole compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180714